These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 10540187)

  • 1. Activation of human neutrophils by mycobacterial phenolic glycolipids.
    Fäldt J; Dahlgren C; Karlsson A; Ahmed AM; Minnikin DE; Ridell M
    Clin Exp Immunol; 1999 Nov; 118(2):253-60. PubMed ID: 10540187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specificity of Mycobacterium tuberculosis phenolic glycolipid (PGL-Tb1) antiserum.
    Papa F; Laszlo A; David HL
    Ann Inst Pasteur Microbiol; 1988; 139(5):535-45. PubMed ID: 2472828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trisaccharides of Phenolic Glycolipids Confer Advantages to Pathogenic Mycobacteria through Manipulation of Host-Cell Pattern-Recognition Receptors.
    Arbués A; Malaga W; Constant P; Guilhot C; Prandi J; Astarie-Dequeker C
    ACS Chem Biol; 2016 Oct; 11(10):2865-2875. PubMed ID: 27548027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuberculin skin testing and in vitro T cell responses to ESAT-6 and culture filtrate protein 10 after infection with Mycobacterium marinum or M. kansasii.
    Arend SM; van Meijgaarden KE; de Boer K; de Palou EC; van Soolingen D; Ottenhoff TH; van Dissel JT
    J Infect Dis; 2002 Dec; 186(12):1797-807. PubMed ID: 12447766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thin-layer chromatography systems for the identification of Mycobacterium tuberculosis, M. bovis BCG, M. kansasii, M. gastri and M. marinum.
    Laszlo A; Papa F; David HL
    Res Microbiol; 1992 Jun; 143(5):519-24. PubMed ID: 1448628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deciphering the genetic bases of the structural diversity of phenolic glycolipids in strains of the Mycobacterium tuberculosis complex.
    Malaga W; Constant P; Euphrasie D; Cataldi A; Daffé M; Reyrat JM; Guilhot C
    J Biol Chem; 2008 May; 283(22):15177-84. PubMed ID: 18390543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of human lymphoproliferative responses by mycobacterial phenolic glycolipids.
    Fournie JJ; Adams E; Mullins RJ; Basten A
    Infect Immun; 1989 Nov; 57(11):3653-9. PubMed ID: 2572559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonopsonic phagocytosis of zymosan and Mycobacterium kansasii by CR3 (CD11b/CD18) involves distinct molecular determinants and is or is not coupled with NADPH oxidase activation.
    Le Cabec V; Cols C; Maridonneau-Parini I
    Infect Immun; 2000 Aug; 68(8):4736-45. PubMed ID: 10899880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural elucidation of new phenolic glycolipids from Mycobacterium tuberculosis.
    Watanabe M; Yamada Y; Iguchi K; Minnikin DE
    Biochim Biophys Acta; 1994 Jan; 1210(2):174-80. PubMed ID: 8280767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The carbohydrate- and lipid-containing cell wall of mycobacteria, phenolic glycolipids: structure and immunological properties.
    Puzo G
    Crit Rev Microbiol; 1990; 17(4):305-27. PubMed ID: 2206395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenolic glycolipid-1 from M. leprae inhibits oxygen free radical production by human mononuclear cells.
    Launois P; Blum L; Dieye A; Millan J; Sarthou JL; Bach MA
    Res Immunol; 1989; 140(9):847-55. PubMed ID: 2697907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Both phthiocerol dimycocerosates and phenolic glycolipids are required for virulence of Mycobacterium marinum.
    Yu J; Tran V; Li M; Huang X; Niu C; Wang D; Zhu J; Wang J; Gao Q; Liu J
    Infect Immun; 2012 Apr; 80(4):1381-9. PubMed ID: 22290144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biosynthesis of cell envelope-associated phenolic glycolipids in Mycobacterium marinum.
    Vergnolle O; Chavadi SS; Edupuganti UR; Mohandas P; Chan C; Zeng J; Kopylov M; Angelo NG; Warren JD; Soll CE; Quadri LE
    J Bacteriol; 2015 Mar; 197(6):1040-50. PubMed ID: 25561717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of monoclonal antibody to a phenolic glycolipid of Mycobacterium tuberculosis and its use in detection of the antigen in clinical isolates.
    Cho SN; Shin JS; Daffe M; Chong Y; Kim SK; Kim JD
    J Clin Microbiol; 1992 Dec; 30(12):3065-9. PubMed ID: 1452686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigen 85C on Mycobacterium bovis, BCG and M. tuberculosis promotes monocyte-CR3-mediated uptake of microbeads coated with mycobacterial products.
    Hetland G; Wiker HG
    Immunology; 1994 Jul; 82(3):445-9. PubMed ID: 7959881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partners in Crime: Phenolic Glycolipids and Macrophages.
    Singh AK; Bishai WR
    Trends Mol Med; 2017 Nov; 23(11):981-983. PubMed ID: 28969977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fishing for Answers in Human Mycobacterial Infections.
    Bolz M; Ernst JD
    Immunity; 2017 Sep; 47(3):395-397. PubMed ID: 28930653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fast atom bombardment mass spectrometry of mycobacterial phenolic glycolipids.
    Hartmann S; Minnikin DE; Mallet AI; Ridell M; Rigouts L; Portaels F
    Biol Mass Spectrom; 1994 Jun; 23(6):362-8. PubMed ID: 8038230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of three glycosyltransferases involved in the biosynthesis of the phenolic glycolipid antigens from the Mycobacterium tuberculosis complex.
    Pérez E; Constant P; Lemassu A; Laval F; Daffé M; Guilhot C
    J Biol Chem; 2004 Oct; 279(41):42574-83. PubMed ID: 15292272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of Genome Region of Difference 4 (RD4) on Mycobacterial Virulence and BCG Efficacy.
    Ru H; Liu X; Lin C; Yang J; Chen F; Sun R; Zhang L; Liu J
    Front Cell Infect Microbiol; 2017; 7():239. PubMed ID: 28642843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.